Literature DB >> 30838381

Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis.

Alexander Dao1, Mohamed Abidian1, Aimee Lestrange1, Mark Mattar1, Amol Rangnekar1, Aline Charabaty2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30838381     DOI： 10.1093/ibd/izz027

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  3 in total

1.  Vancomycin Is Effective in the Treatment of Chronic Inflammatory Conditions of the Pouch.

Authors:  Gabriel Lupu; Kimberly N Weaver; Hans H Herfarth; Edward L Barnes
Journal:  Inflamm Bowel Dis       Date:  2022-10-03       Impact factor: 7.290

2.  A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.

Authors:  Mohammed Nabil Quraishi; Animesh Acharjee; Andrew D Beggs; Richard Horniblow; Chris Tselepis; Georgios Gkoutos; Subrata Ghosh; A E Rossiter; Nicholas Loman; Willem van Schaik; David Withers; Julian R F Walters; Gideon M Hirschfield; Tariq H Iqbal
Journal:  J Crohns Colitis       Date:  2020-07-30       Impact factor: 9.071

Review 3.  Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.

Authors:  Ayesha Shah; Graeme A Macdonald; Mark Morrison; Gerald Holtmann
Journal:  Am J Gastroenterol       Date:  2020-06       Impact factor: 12.045
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.